Sarideechaigul
W, Priprem A, Limsitthichaikoon S, Phothipakdee P, Chaijit R, Jorns TP,
Lungruammit N, Chaiya K. Efficacy and safety of two artificial saliva-based
polymers containing 0.1% pilocarpine for treatment of xerostomia: A randomized
clinical pilot trial. J Clin Exp Dent. 2021;13(10):e994-1000.
doi:10.4317/jced.58415
https://doi.org/10.4317/jced.58415
___________
References
|
1.
Saleh J, Figueiredo MAZ, Cherubini K, Salum FG. Salivary hypofunction: an
update on aetiology, diagnosis and therapeutics. Arch Oral Biol.
2015;60:242-55. |
|
|
|
|
|
2.
Villa A, Wolff A, Aframian D, Vissink A, Ekström J, Proctor G, et al. World
Workshop on Oral Medicine VI: a systematic review of medication-induced
salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral
Investig. 2015;19:1563-80. |
|
|
|
|
|
3.
Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J.
2010;55:238-44. |
|
|
|
|
|
4.
Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of
xerostomia. Clin Dermatol. 2017;35:468-76. |
|
|
|
|
|
5.
Lysik D, Niemirowicz-Laskowska K, Bucki R, Tokajuk G, Mystkowska J.
Artificial saliva: challenges and future perspectives for the treatment of
xerostomia. Int J Mol Sci. 2019;20:3199. |
|
|
|
|
|
6.
Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover
trial of Oral Balance gel and Biotene® toothpaste versus placebo in patients
with xerostomia following radiation therapy. Oral Oncol. 1999;35:132-7. PMid:10435146 |
|
|
|
|
|
7.
Momm F, Volegova-Neher NJ, Schulte-Mönting J, Guttenberger R. Different
saliva substitutes for treatment of xerostomia following radiotherapy: a
prospective crossover study. Strahlenther Onkol. 2005;181:231-6. |
|
|
|
|
|
8.
Oh DJ, Lee JY, Kim YK, Kho HS. Effects of carboxymethylcellulose (CMC)-based
artificial saliva in patients with xerostomia. Int. J Oral Maxillofac Surg.
2008;37:1027-31. |
|
|
|
|
|
9.
Cifuentes M, Del Barrio-Díaz P, Vera-Kellet C. Pilocarpine and artificial
saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome:
a double-blind randomized controlled trial. Br J Dermatol. 2018;179:1056-61. |
|
|
|
|
|
10.
J Pytko-Polonczyk J, Jakubik A, Przeklasa-Bierowiec A, Muszynska B.
Artificial saliva and its use in biological experiments. J Physiol Pharmacol.
2017;68:807-13. PMid:29550792 |
|
|
|
|
|
11.
Gelhard TB, Fidler V, 's-Gravenmade EJ, Vissink A. Remineralization of
softened human enamel in mucin-or CMC-containing artificial salivas. J Oral
Pathol Med. 1983;12:336-41. |
|
|
|
|
|
12.
Javanbakht S, Shaabani A. Carboxymethyl cellulose-based oral delivery
systems. Int J Biol Macromol. 2019;15;133:21-9. |
|
|
|
|
|
13.
Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling,
mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2:53-61. PMid:10952770 |
|
|
|
|
|
14.
Gu JM, Robinson JR, Leung SH. Binding of acrylic polymers to mucin/epithelial
surfaces structure-property relationship. Crit Rev Ther Drug Carrier Syst.
1988;5:21-67. PMid:3293807 |
|
|
|
|
|
15.
Pronin AN, Wang Q, Slepak VZ. Teaching an Old Drug New Tricks: Agonism,
Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic
Acetylcholine Receptor. Mol Pharmacol. 2017;92:601-12. |
|
|
|
|
|
16.
Bernardi R, Perin C, Becker FL, Ramos GZ, Gheno GZ, Lopes LR, et al. Effect
of pilocarpine mouthwash on salivary flow. Braz J Med Biol Res.
2002;35:105-10. |
|
|
|
|
|
17.
Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W. Efficacy
of pilocarpine lozenge for post-radiation xerostomia in patients with head
and neck cancer. Aust Dent J. 2006;51:333-7. |
|
|
|
|
|
18.
Kim JH, Ahn HJ, Choi JH, Jung DW, Kwon JS. Effect of 0.1% pilocarpine
mouthwash on xerostomia: double-blind, randomised controlled trial. J Oral
Rehabil. 2014;41:226-35. |
|
|
|
|
|
19.
Tanigawa T, Yamashita JI, Sato T, Shinohara A, Shibata R, Ueda H, et al. Efficacy
and safety of pilocarpine mouthwash in elderly patients with xerostomia. Spec
Care Dentist. 2015;35:164-9. |
|
|
|
|
|
20.
Pereira RM, Bastos MD, Ferreira MP, de Freitas O, de Macedo LD, de Oliveira
HF, et al. Topical pilocarpine for xerostomia in patients with head and neck
cancer treated with radiotherapy. Oral Dis. 2020;26:1209-18. |
|
|
|
|
|
21.
Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a
multi-item approach to measuring dry mouth. Community Dent Health.
1999;16:12-7. PMid:10697349 |
|
|
|
|
|
22.
Osailan SM, Pramanik R, Shirlaw P, Proctor GB, Challacombe SJ. Clinical
assessment of oral dryness: development of a scoring system related to
salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral
Radiol. 2012;114:597-603. |
|
|
|
|
|
23.
Ferguson MM, Hayes P, Highton J, Jones DS, MacFadyen EE, Palmer DG.
Pilocarpine oral solution. Br Dent J. 1991;170:251. |
|
|
|
|
|
24.
Sakuramoto A, Hasegawa Y, Sugahara K, Komoda Y, Hasegawa K, Hikasa S, et al.
New paste for severe stomatitis in patients undergoing head-and-neck cancer
radiotherapy and/or chemotherapy with oral appliance. BMC Cancer.
2018;18:245. |
|
|
|
|
|
25.
LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, et al. A
multicenter, randomized, double-blind, placebo-controlled, dose-titration
study of oral pilocarpine for treatment of radiation-induced xerostomia in
head and neck cancer patients. J Clin Oncol. 1993;11:1124-31. |
|
|
|
|
|
26.
Furumoto EKBG, Carter-Hanson C, Barber BF. Subjective and clinical evaluation
of oral lubricants in xerostomic patients. Spec Care Dentist. 1998;18:113-8. |
|
|
|
|
|
27.
Marín C, Díaz-de-Valdés L, Conejeros C, Martínez R, Niklander S.
Interventions for the treatment of xerostomia: A randomized controlled
clinical trial. J Clin Exp Dent. 2021 Feb 1;13(2):e104-11. |
|
|
|
|
|
28.
Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Sumitsawan Y, Sittitrai
P, Pattarasakulchai T, et al. Effect of oral pilocarpine on post-irradiation
xerostomia in head and neck cancer patients: a single-center, single-blind
clinical trial. J Med Assoc Thai. 2008;91:1410-5. PMid:18843872 |
|
|
|
|